Percutaneous transluminal angioplasty. Results and surgical implications

Insights

Percutaneous transluminal angioplasty (PTA) offers a 46% patency rate over 36 months. Combining PTA with vascular bypass surgery significantly improves long-term outcomes, especially for iliac interventions.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Endovascular Procedures

Background:

  • Percutaneous transluminal angioplasty (PTA) is a minimally invasive endovascular technique used to open narrowed or blocked arteries.
  • Vascular disease management often involves complex surgical interventions, with varying success rates and complication profiles.

Purpose of the Study:

  • To evaluate the long-term outcomes and safety of percutaneous transluminal angioplasty (PTA) in patients with peripheral arterial disease.
  • To compare the efficacy of PTA in different arterial segments (iliac vs. femoropopliteal).
  • To assess the role of PTA as an adjunct to traditional vascular surgery.

Main Methods:

  • Retrospective analysis of 91 percutaneous transluminal angioplasty procedures in 80 patients.
  • Life-table analysis was used to determine patency rates over a 36-month follow-up period.
  • Factors influencing success rates, including predilatation ankle-brachial index, diabetes, rest pain, necrosis, and age, were analyzed.

Main Results:

  • Overall 36-month patency rate was 46%.
  • Success rates were lower in patients with ankle-brachial ratios < 0.45, diabetes, rest pain/necrosis, and older age.
  • Iliac angioplasty (58% success) outperformed femoropopliteal angioplasty (18% success).
  • Complication rate was low (4% required surgery).
  • Combination of iliac angioplasty with bypass grafting achieved >85% long-term patency.

Conclusions:

  • Percutaneous transluminal angioplasty (PTA) demonstrates moderate long-term patency and a low complication rate, making it a viable option for select vascular patients.
  • PTA is particularly effective for iliac artery interventions and significantly enhances outcomes when combined with bypass surgery.
  • Vascular surgeons should consider PTA as both an alternative and an adjunct therapy for managing peripheral arterial disease.